Clinical Trials on Refractory Central Nervous System Lymphoma
Total 142238 results
-
Huiqiang HuangGuangdong 999 Brain HospitalNot yet recruitingNon Hodgkin Lymphoma | PCNSL | Refractory and Relapsed Primary CNS LymphomaChina
-
Stanford UniversityTerminatedMycosis Fungoides | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous LymphomaUnited States
-
FBD Biologics LimitedRecruitingAdvanced Solid Tumor | Refractory Non-Hodgkin LymphomaTaiwan, United States
-
BayerActive, not recruitingRelapsed or Refractory Indolent Non-Hodgkin LymphomaTaiwan
-
HutchmedRecruitingRelapsed/Refractory LymphomaChina
-
Actuate Therapeutics Inc.RecruitingNeuroblastoma | Pediatric Cancer | Diffuse Intrinsic Pontine Glioma | Pediatric Brain Tumor | Refractory Cancer | Refractory Neoplasm | Refractory Tumor | Cancer Pediatric | Neuroblastoma Recurrent | Pediatric Lymphoma | Pediatric MeningiomaUnited States
-
Chinese PLA General HospitalRecruitingStudy of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid TumorsAdvanced Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaChina
-
Peking University Cancer Hospital & InstituteRecruitingRelapsed/Refractory B-cell Non-Hodgkin LymphomaChina
-
Curon Biopharmaceutical (Shanghai) Co.,LtdRecruitingRelapsed or Refractory B-Cell Non-Hodgkin LymphomaChina
-
Janssen Research & Development, LLCMayo ClinicRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia, Israel
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark
-
Cellular Biomedicine Group Ltd.Tianjin Medical University Cancer Institute and HospitalUnknownRefractory or Relapsed B-cell Non-Hodgkin LymphomaChina
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
Waterstone Hanxbio Pty LtdRecruitingRelapsed/Refractory LymphomaChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.TerminatedRelapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL)China
-
National Taiwan University HospitalCompletedRefractory Lymphoma | Relapsed Non Hodgkin LymphomaTaiwan
-
Chinese PLA General HospitalRecruitingRelapsed or Refractory Hodgkin LymphomaChina
-
Fondazione Italiana Linfomi - ETSRoche Pharma AGRecruitingRelapsed or Refractory Hodgkin's LymphomaItaly
-
Jennifer WoyachKaryopharm Therapeutics IncActive, not recruitingRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
CARGO TherapeuticsRecruitingCancer | Relapsed/Refractory Large B-cell Lymphoma (LBCL)United States
-
Tarapeutics Science Inc.RecruitingAdvanced Solid Tumor | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryChina
-
Fondazione Italiana Linfomi - ETSTerminatedT-Cell Lymphoma Relapsed | T-Cell Lymphoma RefractoryItaly
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Recurrent Indolent Adult Non-Hodgkin LymphomaUnited States
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Aggressive B-Cell LymphomaUnited States, Germany, Spain
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Peripheral T-cell LymphomaChina
-
Sun Yat-sen UniversityRecruitingRelapsed or Refractory Peripheral T-cell LymphomaChina
-
Astex Pharmaceuticals, Inc.Active, not recruitingRelapsed/Refractory Peripheral T-cell LymphomaSpain, United States, Australia, France, United Kingdom, Italy, Poland
-
Dizal PharmaceuticalsCompletedRelapsed or Refractory Peripheral T Cell LymphomaKorea, Republic of, United States, China, Australia
-
Samsung Medical CenterCompletedPrimary Mediastinal Large B-cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaKorea, Republic of
-
Beijing Boren HospitalActive, not recruitingAcute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia, in Relapse | Refractory Acute Lymphoid LeukemiaChina
-
Multinational Center for Quality of Life Research...UnknownRelapsed or Refractory Hodgkin's LymphomaRussian Federation
-
Ohio State University Comprehensive Cancer CenterAmgenCompletedHematopoietic/Lymphoid Cancer | Recurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Affimed GmbHArtiva Biotherapeutics, Inc.RecruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
Samsung Medical CenterCompletedRelapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin LymphomaKorea, Republic of
-
Sun Yat-sen UniversityNot yet recruitingRelapsed and Refractory Peripheral T-cell LymphomaChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownRelapsed/Refractory Anaplastic Large Cell Lymphoma (ALCL)China
-
Astellas Pharma IncTerminatedLymphoma, Large-Cell, Diffuse | Lymphoma, B-Cell RefractoryFrance, Spain, United States, Canada
-
MingSight Pharmaceuticals, IncShenzhen MingSight Relin Pharmaceutical Co., LtdRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Relapsed or Refractory B-cell Lymphoma | Marginal Zone Lymphoma (MZL)China
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingHodgkin Lymphoma | Relapse | RefractoryUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedLymphoma | Refractory or Relapsed Solid TumorsKorea, Republic of, United States, Canada, Belgium, Denmark
-
Telios Pharma, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed/Refractory B Cell Malignancies | Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma | Treatment-Naive B Cell MalignanciesUnited States, Poland, Ukraine, Hungary, Italy, Russian Federation, United Kingdom
-
Bausch Health Americas, Inc.CompletedRefractory Cutaneous T-cell LymphomaUnited States
-
University Hospital, BordeauxCompletedRefractory Primary-cutaneous Large B-cell Lymphoma (Leg-type)France
-
Auxilio Mutuo Cancer CenterCompletedRefractory Aggressive Non-Hodgkin's Lymphoma | Relapsing Aggressive Non-Hodgkin's Lymphoma